T&L Co., Ltd. Stock

Equities

A340570

KR7340570001

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 06:00:00 2024-05-27 pm EDT 5-day change 1st Jan Change
62,500 KRW +0.64% Intraday chart for T&L Co., Ltd. -5.30% +56.25%
Sales 2024 * 140B 103M Sales 2025 * 171B 126M Capitalization 505B 371M
Net income 2024 * 36B 26.46M Net income 2025 * 45B 33.08M EV / Sales 2024 * 3.04 x
Net cash position 2024 * 78.8B 57.92M Net cash position 2025 * 110B 81.22M EV / Sales 2025 * 2.3 x
P/E ratio 2024 *
14 x
P/E ratio 2025 *
11.1 x
Employees 142
Yield 2024 *
1.12%
Yield 2025 *
1.4%
Free-Float 53.11%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.64%
1 week-5.30%
Current month+3.48%
1 month+4.34%
3 months+29.80%
6 months+45.35%
Current year+56.25%
More quotes
1 week
60 600.00
Extreme 60600
68 200.00
1 month
56 600.00
Extreme 56600
71 600.00
Current year
37 500.00
Extreme 37500
71 600.00
1 year
37 500.00
Extreme 37500
71 600.00
3 years
28 800.00
Extreme 28800
71 600.00
5 years
18 225.00
Extreme 18225
71 600.00
10 years
18 225.00
Extreme 18225
71 600.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 -
Chief Tech/Sci/R&D Officer 54 -
Director/Board Member 55 -
Members of the board TitleAgeSince
Director/Board Member 60 -
Chief Executive Officer 65 -
Director/Board Member 59 -
More insiders
Date Price Change Volume
24-05-28 62,500 +0.64% 156,476
24-05-27 62,100 -1.43% 215,443
24-05-24 63,000 0.00% 219,085
24-05-23 63,000 -0.63% 311,781
24-05-22 63,400 -6.07% 314,756

End-of-day quote Korea S.E., May 27, 2024

More quotes
T&L Co Ltd is a Korea-based company engaged in the manufacture and sale of wound treatment materials. The Company's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The company sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
62,500 KRW
Average target price
71,500 KRW
Spread / Average Target
+14.40%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A340570 Stock